English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Cancer is one of the leading causes of death around the world [1]. There are a number of challenges that the limitation of new drugs to potentiate antitumor therapies [2]. Furthermore, despite a positive response to initial treatment, many patients eventually develop a local recurrence and spread of the primary tumor [3–5]. Additional prognostic biomarkers are urgently needed to improve decision making regarding adjuvant therapy for these patients.

Novel Medicines and Strategies in Cancer Treatment and Prevention